articleThe LancetAug 1, 2004Closed access

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

TJThomas J. SchnitzerGRGerd R BurmesterEMEduardo MyslerMCMarc C. HochbergMDMichael Doherty

Northwestern University · Humboldt-Universität zu Berlin · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

701
total citations
FWCI
59.38
Percentile
100%
References
42
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Medicine
  • Ibuprofen
  • Naproxen
  • Aspirin
  • Internal medicine
  • Adverse effect
  • Clinical endpoint
  • Diclofenac
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding